FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics and gynaecology, and can be used for reducing a risk of the foetoplacental system organs involvement in the third trimester of gestation in aggravated herpes viral infection in the 12th week of gestation. That is ensured by intravenous drop-by-drop infusion of human immunoglobulin 25 ml in the 16th and 24th weeks of pregnancy three times every second day.
EFFECT: method enables reducing the foetoplacental system organs involvement by preventing a great amount of serotonin.
Authors
Dates
2014-10-10—Published
2012-11-22—Filed